So much has changed since last year’s Inspections Summit that it sometimes feels difficult to keep up. The FDA is focused on any number of new topics: more generics, lower prices, opioids, internal restructuring, and much more. But one thing that hasn’t changed is that they are still doing inspections….and the regulated community is still making mistakes.
The FDA will always — always — do inspections, and Commissioner Scott Gottlieb and the FDA have certainly not provided any hint that they are going to stop doing them any time soon.
You can’t afford to be caught off guard. Warning letters, 483 citations, and hits to your reputation can cost you time, energy and money!
Come to Washington, DC, Oct. 23-25, for the 13th Annual FDA Inspections Summit, the must-attend conference of the regulatory year from FDAnews. Here’s where you:
Meet the FDAers whose actions spell fortune — or failure ... lawyers and consultants who fight for you ... industry hot-shots who’ve sussed out how to navigate a hyper-regulated milieu — and still prosper.
Drug, device and clinical separate tracks. There’ll be panels galore aimed specifically at the particular issues that affect drug and device makers and clinical trials professionals.
Pre-Conference Drug, Device and Clinical Workshops filled with tips and tricks to help yousail through your next inspection.
So mark your calendar and book reservations early. The FDA Inspections Summit is coming. You will be well advised to attend. Register TODAY.